Sign in
4

Changes in Ownership

DiaMedica Therapeutics Inc. Filed Acc 0001235802-19-000064

Options or other derivatives

  • President and CEO acquired 264,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Pauls Dietrich John President and CEO 2019-06-24 Grant or award · Stock Option (right to buy) +264,000 264,000 D
Loading xslF345X03/primary_doc.xml…